SecBot SecBot
SECBOTREPLAY Home › Report › IOVA

IOVA · State Street 4.8% stake

IOVANCE BIOTHERAPEUTICS, INC. · SC 13G filed Nov 10, 2026 at 08:22 ET

At the news

NEUTRALIMPACT 3/10

SC 13G filed Nov 10, 2026 at 08:22 ET

State Street Corp disclosed a 4.8% passive stake in Iovance Biotherapeutics as of September 30, 2026, via a Schedule 13G filing. This is a routine update of its existing passive position, consistent with prior filings, and follows the company's strong Q3 earnings report.

  • State Street Corp reported beneficial ownership of 21,695,003 shares of Iovance common stock as of September 30, 2026.
  • The stake represents 4.8% of shares outstanding.
  • The filing is a Schedule 13G, certifying passive investment intent with no control or influence purpose.
  • State Street has filed multiple prior 13Gs for Iovance, indicating a continuing passive position.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access